Skip to main content
Equibles

Invesco Ltd.

Position in HUMA — Humacyte, Inc.

CIK 914208 Atlanta, GA
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$199,316
+$94,650 QoQ
Shares Held
255,534
+48.2% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 163 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. HUMA ranks #244 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in HUMA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $199,316 255,534
2026-03-31 $104,666 172,435
2025-12-31 $37,308 38,824
2025-09-30 $58,715 33,745
2025-06-30 $62,265 29,793
2025-03-31 $51,395 30,145
2024-12-31 $156,179 30,927
2024-09-30 $160,419 29,489
2024-06-30 $126,000 26,250
2024-03-31 $68,260 21,949
2023-12-31 $59,903 21,093
2023-09-30 $69,276 23,644
2023-06-30 $67,449 23,584
2023-03-31 $71,835 23,248
2022-12-31 $55,662 26,381
2022-09-30 $65,280 20,025
2022-06-30 $61,846 19,267